Market Tracker

01/18 4:47am ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

363.24
Delayed Data
As of Jan 17
 -4.92 / -1.34%
Today’s Change
325.35
Today|||52-Week Range
484.57
-1.05%
Year-to-Date
Key FDA Events to Watch Out for in Q1
Jan 17 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regen...
Jan 10 / Zacks.com - Paid Partner Content
Drugmakers alarmed by Trump pricing threat
Jan 14 / FT.com - Paid Partner Content
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit
Jan 10 / Zacks.com - Paid Partner Content
Sanofi confident it can overturn Praluent patent ruling
Jan 12 / FT.com - Paid Partner Content
Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes
Jan 10 / MotleyFool.com - Paid Partner Content
Stock Market News for January 11, 2017
Jan 11 / Zacks.com - Paid Partner Content
The 10 Worst Stocks in the Nasdaq in 2016
Jan 09 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short
Jan 11 / Zacks.com - Paid Partner Content
Company News for January 09, 2017
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close368.16
Today’s open367.65
Day’s range359.73 - 369.97
Volume879,176
Average volume (3 months)910,287
Market cap$38.8B
Dividend yield--
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-3.67%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+45.55%
P/E ratio53.0
Price/Sales15.24
Price/Book10.54

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-1.63-1.19%
ZTSZoetis Inc-0.52-0.97%
SHPGShire-2.05-1.20%
BAXBaxter International...+0.07+0.15%
Data as of 01/17/2017

Financials

Next reporting dateFebruary 14, 2017
EPS forecast (this quarter)$3.13
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Scientific Officer
George Damis Yancopoulos
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts